These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23383702)

  • 1. Opportunities and challenges of specialty pharmaceuticals.
    Navarro RP; Johnson KA
    J Manag Care Pharm; 2013; 19(1):70-1. PubMed ID: 23383702
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare risk programs and pharmacy benefits managers.
    Herzfeld J
    Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Part D: who wins, who loses?
    Am Fam Physician; 2006 Feb; 73(3):401. PubMed ID: 16477886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering new strategies in specialty pharmacy management.
    Edlin M
    AHIP Cover; 2004; 45(5):34-9. PubMed ID: 15499743
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 7. Incentives in the Medicare prescription drug benefit.
    Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
    [No Abstract]   [Full Text] [Related]  

  • 8. Was Part D a giveaway to the pharmaceutical industry?
    Newhouse JP; Seiguer E; Frank RG
    Inquiry; 2007; 44(1):15-25. PubMed ID: 17583259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare overpaid dollar 110 million for part B drugs.
    Med Health; 2006 Mar; 60(13):2-3. PubMed ID: 16562555
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare prescription drugs: making the new program work.
    Jaffe J
    EBRI Issue Brief; 2004 Jun; (270):1-14. PubMed ID: 15218820
    [No Abstract]   [Full Text] [Related]  

  • 11. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and Medical Devices: Medicare Part D.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-34. PubMed ID: 30695850
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug expenditures, financial burden and health plan satisfaction among medicare beneficiaries.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(5):453-4, 455-6. PubMed ID: 14613446
    [No Abstract]   [Full Text] [Related]  

  • 14. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-pocket prescription costs a continuing burden under Medicare Part D.
    Am Fam Physician; 2006 Feb; 73(3):402. PubMed ID: 16477887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialty Drugs - A Distinctly American Phenomenon.
    Naci H; Kesselheim AS
    N Engl J Med; 2020 Jun; 382(23):2179-2181. PubMed ID: 32492301
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare Part D: practical and policy implications for family physicians.
    Mallya G; Bazemore A
    Am Fam Physician; 2006 Feb; 73(3):395-6. PubMed ID: 16477884
    [No Abstract]   [Full Text] [Related]  

  • 18. What you need to know about Medicare Part D.
    Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
    [No Abstract]   [Full Text] [Related]  

  • 19. A multidimensional framework for specialty drug management.
    Bell GK; Baumann SA
    Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing the intersection of medical and pharmacy benefits.
    McDonald RC
    J Manag Care Pharm; 2008 May; 14(4 Suppl):S7-11. PubMed ID: 18507508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.